Hammarvik anestesi AB

Active
559347-4413Limited company (AB)Registered 2021ÖJERSJÖ

Key figures

112 000 kr−90,8%
Revenue 2025
−54,8%
Average annual change 2022–2025
0500 k1 m1,5 m2022202320242025

Key figures

2025

Summary: Hammarvik anestesi AB

What kind of company is it?

Hammarvik anestesi AB (org. no. 559347-4413) is a limited company (AB). The company was registered in 2021 and has existed for 5 years. Registered seat: Öjersjö. Industry according to Statistics Sweden: specialised hospital somatic activities (SNI 86102).

How is the company doing financially?

Net sales in financial year 2025 were 112 000 kr, down 90,8 % on the previous year (1 215 000 kr). From 2022 to 2025, net sales declined by an average of 54,8 % per year. This is the lowest net sales among the reported years (2022–2025). Financial year 2025 ended with a loss of 60 291 kr. The company was profitable in 3 of the 4 reported financial years. Employees in financial year 2025: 1. Net sales per employee were 112 000 kr. At the end of financial year 2025, total assets were 1 140 297 kr and equity 1 137 759 kr (equity ratio 99,8 %).

Where does the data come from and how up to date is it?

Company details and digitally filed annual reports come from the open data of the Swedish Companies Registration Office (Bolagsverket) and the industry code from Statistics Sweden (CC BY 2.5 SE); bolagsprofil.se updates them daily. The latest annual report is signed by one person. Data as of 2026-11-16. Changes, averages and ratios are calculated by bolagsprofil.se from open data and are not an official assessment.

Summary of annual reports2022–2025
2022202320242025
Sales revenue1 214 0001 446 0001 215 000112 000
Profit for the reporting year421 356493 326258 368−60 291
Retained earnings of previous periods————
Total assets661 9601 251 1951 367 2631 140 297
Total liabilities215 604311 514169 2132 538
Total equity446 356939 6811 198 0501 137 759
Employees1111

A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.